Uluru Co., Ltd. (3979) Stock Forecast & Analysis
Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Uluru Co., Ltd. (3979:JPX), powered by AI.
- Current Price
- ¥389
- P/E Ratio
- 22.7
- Market Cap
- 10.4B
- Sector
- Technology
What is the Uluru Co., Ltd. stock price forecast?
Uluru Co., Ltd. is currently trading at ¥389. View real-time AI analysis on Alpha Lenz.
What is Uluru Co., Ltd. insider trading activity?
View the latest insider trading data for Uluru Co., Ltd. on Alpha Lenz.
What is Uluru Co., Ltd.'s P/E ratio?
Uluru Co., Ltd.'s P/E ratio is 22.7.
Uluru Co., Ltd.
JPX · 3979“Uluru Co., Ltd. trades at a P/E of 22.7 (fair value) with strong ROE of 15.7%. 3Y revenue CAGR of 18.5% highlights clear growth momentum.”
Ask for details →Company Overview
Uluru Co., Ltd. is a prominent entity in the pharmaceutical industry, recognized for its innovative drug delivery technologies. Specializing in advanced research and development, the company's core mission is to enhance patient outcomes through novel medical solutions. Uluru Co., Ltd. focuses on creating drug delivery systems that optimize therapeutic efficacy and patient compliance. Its major contributions include the development of transmucosal and adhesive technologies that provide targeted, controlled release of medications. The company significantly impacts the healthcare industry, particularly in pain management and wound care sectors. Through strategic partnerships and continuous innovation, Uluru Co., Ltd. maintains a vital role in meeting the global demand for improved medical treatments.
Company Statistics
FY 2025Profile
Margins
Valuation
Growth (CAGR)
Returns
Financial Health
“Uluru Co., Ltd. trades at a P/E of 22.7 (fair value) with strong ROE of 15.7%. 3Y revenue CAGR of 18.5% highlights clear growth momentum.”
Ask for details →Frequently Asked Questions
Uluru Co., Ltd. (ticker: 3979) is a company listed on JPX in the Technology sector (Information Technology Services). It has approximately 268 employees. Market cap is $10.4B.
The current price is 389 with a P/E ratio of 22.72x and P/B of 3.44x.
ROE is 15.69% and operating margin is 11.38%. Annual revenue is $6.7B.